It seems like AI lets anyone ship anything. So where’s the moat? Our guest says it’s not the model — it’s what happens after you ship that matters most.
Rajiv Jain is Senior VP of Global Product Strategy at AliveCor, maker of the personal ECG that gives you a 30-second, AI-powered heart reading at home. Six million users later, every recording makes the next model smarter. That’s how AliveCor went from detecting one heart condition to six, with 26 on the roadmap.
Before that, Rajiv built Amazon’s Alexa enterprise ecosystem, including work with NASA on an AI companion for the trip to Mars, and a test run on Artemis I around the Moon.
In this episode, Rajiv shares:
Why the smartest bet in AI is a flywheel, not a feature
How to build a roadmap backward from lives saved, then work out the tech
And what building Alexa taught him about AI agents, and why the business model matters more than the tech
So, here’s our episode with Rajiv Jain.
1. Deploying a model creates its own data
AliveCor has a big proprietary dataset, and it also buys data from other sources. But Rajiv argues the most valuable data comes from shipping the model in the first place.
When a patient uses an AliveCor device, they don’t record once. They might take 18 to 28 recordings a month, and keep recording for years. That turns a single snapshot into a longitudinal record.
“So I have not just one point-in-time data, but data over a period of time. In that, I also know what’s a patient demographic, what conditions are they developing over a period of time.”
And patients add more than heart readings. They log how they’re feeling, what they ate, and how active they were. Over time, the model’s inputs go from a single signal to many. That’s what gets each generation of model better than the last:
“Deploying that model creates a flywheel, and then generations of model get better and better and better just because you’re getting more and more types of signals into the model.”
Product takeaway: Don’t wait for the perfect dataset before you ship. Your proprietary data can get you started, but the data your product generates once it’s in customers’ hands is what will compound.
2. Start with lives saved, then work out the tech
Because AliveCor makes its own hardware, Rajiv thinks of its devices as sensors. Add more sensors, and you can capture more data. But what to build next doesn’t start with the data. It starts with the value.
Rajiv gives an example. A doctor in a hospital might use an ECG to detect about 100 conditions. New research suggests the ECG signal could detect up to 600. Some of those conditions currently need an echocardiogram, which can cost hundreds or thousands of dollars and take time to schedule.
“If you can do a low-cost ECG just to be able to detect that condition that you used echo for, then all of a sudden we have reduced friction.”
Now imagine bringing that detection into the patient’s home. That’s the kind of opportunity AliveCor’s roadmap is built around. From there, the team works with doctors to correlate hospital data and patient records with the ECG data AliveCor has gathered over the years, to see whether it can detect a condition reliably.
Only then does the team ask what it can build with the data and signals it has, and what it can take through the FDA and other regulators.
Product takeaway: Build your roadmap backward. Start by quantifying the value for each audience you serve: in AliveCor’s case, lives saved, time to treatment, and cost. Then work out whether your data and tech can deliver it. It keeps the team focused on the outcomes that matter instead of chasing whatever the newest model makes possible.
3. Get every layer of the system to see the value
Plenty of great healthcare products fail because the incentives don’t line up. Patients, providers, and payers all need to see a benefit, or the best tech in the world goes nowhere.
AliveCor started direct to consumer. Patients buy the device out of pocket, so the first job was to serve them well when they’re not in front of a doctor. But the team quickly realized it was also serving the doctors working with those patients.
“50 to 60% of my patient journeys start in a doctor’s office. Because over a period of time, doctors realize that, hey, if the patient’s more educated and they are more informed about their health and they’re empowered, they’ll respond to treatment better.”
Once value is proven with patients and doctors, AliveCor can take that case to payers and employers, in the US and in Europe, covering the financial, medical, and scientific sides of the conversation.
Product takeaway: In a market with many stakeholders, you don’t have to win everyone at once. Pick the one you can serve directly, prove the value there, and use that proof to bring in the next layer. Each win builds the case for the next one.
4. What Alexa taught Rajiv about AI agents
Rajiv joined Alexa around 2016, when voice assistants were just starting to capture people’s imaginations. His job was to take Alexa into the enterprise.
One of the most ambitious projects was with NASA. A trip to Mars could keep astronauts locked in a small space for months or even years. How do you keep them sane, engaged, and productive? Maybe Alexa could help.
“None of us wanted the HAL, open the pod door scenarios. But really thinking about, ‘Hey, what are the mental aspects? What are the challenges an astronaut is going to face?’”
That work led to experiments with NASA, including a test run of Alexa on the Artemis I mission around the Moon. Rajiv’s team also worked with Disney on Disney-branded devices in hotel rooms, where guests could check reservations and showtimes, and a Disney skill that brought some of the park experience home.
Product takeaway: The use cases for AI agents haven’t changed much in a decade. What’s changed is how well the tech can deliver them. Before you start building, look at what earlier waves of assistants tried and where they fell short. And plan for your agent working alongside other agents, with clean handoffs, rather than as a standalone experience.
5. Invest in flywheels, not features.
Rajiv’s hardest-won lesson from Alexa is that great tech isn’t enough on its own:
“Technology is important, customer experiences are important, but the business model and the financials are equally important.”
Amazon could sell the devices, but how would the usage make money? With today’s inference costs, that question matters even more.
His answer is to invest in flywheels: a better model brings more data, which reaches more customers, which makes the model better again, over five or six years.
“Don’t look at a product, don’t look at a feature. Really think about if there’s a flywheel behind it, what does that flywheel look like and how do you make sure you’re making the right investments.”
Product takeaway: Start every bet with a hypothesis about what customers will pay for and how the economics hold up. Then back the investments that feed a flywheel for years, not just a feature for this quarter.
Chapters
00:00 Introduction
03:43 How AliveCor's at-home ECG uses AI to read your heart
06:47 How deployed models create a healthcare data flywheel
10:51 Prioritizing features by lives saved
13:24 Why AliveCor started direct to consumer, then won over doctors and payers
15:54 What building Alexa taught Rajiv about AI companions
19:39 Bringing Alexa to Disney hotel rooms and Disney characters into homes
21:17 Why the business model matters as much as the AI itself
24:57 Alexa's monetization problem and why to invest in five-year flywheels
27:37 Conclusion
Links
What does LogRocket do?
LogRocket’s Galileo AI watches user sessions for you and surfaces the technical and usability issues holding back your web and mobile apps. Understand where your users are struggling by trying it for free at LogRocket.com.

